Current technologies for isolating circulating tumor cells (CTCs) have limited prognostic value because of the low sensitivities, yields and purities associated with these methods. Nagrath et al.

As the presence of tumor cells circulating in the blood is associated ... that exploits the immunofluorescent characterization and isolation of cancer cells. Herein, we analyzed the experimental ...

Circulating tumor cell; DAPI: 4×,6-diamidino-2-phenylindole; EpCAM: Epithelial cell adhesion molecule; EPISPOT: Epithelial ImmunoSPOT; ISET: Isolation by size of epithelial tumor cells ...

Cancer is one of the leading causes of death globally, with nearly 20 million new cases and 9.7 million deaths in 2022.

Human circulating tumor DNA “was overall consistently shorter than the fragment length of normal cell-free DNA,” the authors wrote in their paper. The findings could help improve cancer diagnosis and ...

Tumor cells circulating in the blood are the germ cells of breast cancer metastases. They are very rare and have not been propagated in the culture dish until now, which made research into therapy ...

Dublin, April 03, 2025 (GLOBE NEWSWIRE) -- The "Circulating Tumor Cell Market by Technology Type (CTC Analysis, CTC Detection & Isolation), Product Type (Instruments, Kits & Reagents), Application ...

In collaboration with nano-technology engineers, we developed the “NanoFlare” method that enables the detection and isolation of live circulating tumor cells (CTC), establishing a platform to study ...

Cell.Ai, a global leader in single cell precision diagnostics, has joined forces with BioSkryb Genomics, a pioneer in single cell multi-omics, to co-develop and commercialize next-generation single ...